Tue Apr 27 2021 | Laurel Pfahler | High School
St. Paul’s (Md.) defeated former No. 1 McDonogh (Md.) 16-9 on Wednesday, resulting in another major climb for the Gators.
Christina Gagnon scored five goals to go with three assists, Frannie Hahn and Kendall Steer had three goals apiece and Caitlin McElwee added two goals. Josie Hahn and Lauren Steer each had two assists. St. Paul’s jumped out to a 10-0 lead. Leah Warehime made four saves.
It’s the first regular-season defeat of McDonogh by an IAAM team since 2008.
The Gators then beat Bryn Mawr (Md.) 15-10 on Saturday. Gagnon and McElwee had three goals and one assist apiece, and Lauren Steer, Josie Hahn and Frannie Hahn all contributed two goals apiece, with Lauren Steer adding two assists. Warehime made eight saves.
Tue Apr 20 2021 | Laurel Pfahler | High School
Practices are beginning for several teams in the Northeast and West this week, and some teams have already started to play meaningful games in those regions. For the first time in a long time, lacrosse is back across the entire country.
That will lead to shakeups in the future, but for now, the top of Nike / US Lacrosse High School Girls’ National Top 25 remains largely unchanged. The only notable change is that St. Paul’s (Md.) has entered the top 10 at No. 9 after a 2-0 week. St. Paul’s plays McDonogh on Wednesday in a key in-state matchup.
(1)
EUSA Pharma (UK) Limited (
EUSA Pharma ), a global biopharmaceutical company focused on oncology and rare diseases, announced that the National Comprehensive Cancer Network
(NCCN
) for B-Cell Lymphomas to include siltuximab (SYLVANT
) as the preferred primary treatment for patients with human immunodeficiency virus-negative [HIV(-)] and human herpesvirus 8-negative [HHV-8(-)] multicentric Castleman disease (MCD), also known as idiopathic multicentric Castleman disease (iMCD), regardless of histopathologic subtype.
1 Siltuximab is currently approved in more than 40 countries worldwide for the treatment of all histopathologic subtypes of iMCD, a rare, life-threatening and debilitating orphan condition of the lymph nodes and related tissues. 2,3 The update is based on a 2020 publication which demonstrated that there is insufficient evidence to guide treatment based solely on lymph node histopathologic subtype.
Press release content from Business Wire. The AP news staff was not involved in its creation.
EUSA Pharma and BeiGene Announce Acceptance of a Biologics License Application for SYLVANT® (Siltuximab for Injection) in China
January 25, 2021 GMT
HEMEL HEMPSTEAD, England & BEIJING, China & CAMBRIDGE, Mass. (BUSINESS WIRE) Jan 25, 2021
EUSA Pharma (UK) Limited and BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160) today announced that the Biologics License Application (BLA) for SYLVANT ® (siltuximab for injection) was accepted by the China National Medical Products Administration (NMPA) and granted priority review. Siltuximab is a monoclonal antibody approved by the European Medicines Agency (EMA) and Food and Drug Administration (FDA) for the treatment of adult patients with multicentric Castleman’s disease (MCD) who are human immunodeficiency virus (HIV) negative and human herpesvirus-8 (HHV-8) negative, also known as idiopathic MCD (iMCD). iMCD is a rare, life-threatening and debilitat
COLUMBUS, Ohio In the midst of challenging times, volunteers throughout Ohio are showing their commitment to improving their communities. For the Martin Luther King Day of Service today, hundreds of people are taking part in dozens of projects intended to honor the late civil rights leader. Rebeccah Verhoff-Kiss, outreach and education officer for the group Serve Ohio said the idea is to make the holiday a "Day On, Not a Day Off." "Dr. .